Rethinking Alzheimer's disease therapy: are mitochondria the key?

@article{Ankarcrona2010RethinkingAD,
  title={Rethinking Alzheimer's disease therapy: are mitochondria the key?},
  author={Maria Ankarcrona and Francesca Mangialasche and Bengt Winblad},
  journal={Journal of Alzheimer's disease : JAD},
  year={2010},
  volume={20 Suppl 2},
  pages={S579-90}
}
The number of people suffering from Alzheimer's disease (AD) is constantly increasing worldwide since humans live longer and age is the strongest risk factor for AD. Currently available medications for AD do not interfere with the progressive loss of synapses and neurons in the AD brain. Therefore, the development of disease modifying therapies is a major… CONTINUE READING